Review
Open access
2026
Biomarker-Driven Precision Oncology in Advanced Gastroesophageal Adenocarcinoma: Current Standards and Future Directions
The current evidence supporting biomarker-driven treatment strategies in advanced GEA is summarized, practical biomarker testing considerations are highlighted, and ongoing challenges and future directions in precision oncology are discussed.
Fares Jamal, Abdullah Alsulaiman, Oudai Sahwan et al.
· Oncology Research · 0 citations